Literature DB >> 31449057

Restoring public trust in scientific research by reducing conflicts of interest.

Arthur M Feldman1, Douglas L Mann2.   

Abstract

Mesh:

Year:  2019        PMID: 31449057      PMCID: PMC6763216          DOI: 10.1172/JCI131448

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  10 in total

Review 1.  Regenerating the field of cardiovascular cell therapy.

Authors:  Kenneth R Chien; Jonas Frisén; Regina Fritsche-Danielson; Douglas A Melton; Charles E Murry; Irving L Weissman
Journal:  Nat Biotechnol       Date:  2019-02-18       Impact factor: 54.908

2.  A Time to Press Reset and Regenerate Cardiac Stem Cell Biology.

Authors:  Jonathan A Epstein
Journal:  JAMA Cardiol       Date:  2019-02-01       Impact factor: 14.676

3.  Intravenous Allogeneic Mesenchymal Stem Cells for Nonischemic Cardiomyopathy: Safety and Efficacy Results of a Phase II-A Randomized Trial.

Authors:  Javed Butler; Stephen E Epstein; Stephen J Greene; Arshed A Quyyumi; Sergey Sikora; Raymond J Kim; Allen S Anderson; Jane E Wilcox; Nikolai I Tankovich; Michael J Lipinski; Yi-An Ko; Kenneth B Margulies; Robert T Cole; Hal A Skopicki; Mihai Gheorghiade
Journal:  Circ Res       Date:  2016-11-16       Impact factor: 17.367

4.  Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial.

Authors:  Roberto Bolli; Atul R Chugh; Domenico D'Amario; John H Loughran; Marcus F Stoddard; Sohail Ikram; Garth M Beache; Stephen G Wagner; Annarosa Leri; Toru Hosoda; Fumihiro Sanada; Julius B Elmore; Polina Goichberg; Donato Cappetta; Naresh K Solankhi; Ibrahim Fahsah; D Gregg Rokosh; Mark S Slaughter; Jan Kajstura; Piero Anversa
Journal:  Lancet       Date:  2011-11-14       Impact factor: 79.321

Review 5.  Origin of cardiomyocytes in the adult heart.

Authors:  Annarosa Leri; Marcello Rota; Francesco S Pasqualini; Polina Goichberg; Piero Anversa
Journal:  Circ Res       Date:  2015-01-02       Impact factor: 17.367

Review 6.  Cardiomyocyte Regeneration: A Consensus Statement.

Authors:  Thomas Eschenhagen; Roberto Bolli; Thomas Braun; Loren J Field; Bernd K Fleischmann; Jonas Frisén; Mauro Giacca; Joshua M Hare; Steven Houser; Richard T Lee; Eduardo Marbán; James F Martin; Jeffery D Molkentin; Charles E Murry; Paul R Riley; Pilar Ruiz-Lozano; Hesham A Sadek; Mark A Sussman; Joseph A Hill
Journal:  Circulation       Date:  2017-07-06       Impact factor: 29.690

7.  Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study).

Authors:  Victoria Florea; Angela C Rieger; Darcy L DiFede; Jill El-Khorazaty; Makoto Natsumeda; Monisha N Banerjee; Bryon A Tompkins; Aisha Khan; Ivonne H Schulman; Ana Marie Landin; Muzammil Mushtaq; Samuel Golpanian; Maureen H Lowery; John J Byrnes; Robert C Hendel; Mauricio G Cohen; Krystalenia Valasaki; Marietsy V Pujol; Eduard Ghersin; Roberto Miki; Cindy Delgado; Fouad Abuzeid; Mayra Vidro-Casiano; Russell G Saltzman; Daniel DaFonseca; Lina V Caceres; Kevin N Ramdas; Adam Mendizabal; Alan W Heldman; Raul D Mitrani; Joshua M Hare
Journal:  Circ Res       Date:  2017-09-18       Impact factor: 17.367

8.  Financial Relationships With Industry Among National Comprehensive Cancer Network Guideline Authors.

Authors:  Aaron P Mitchell; Ethan M Basch; Stacie B Dusetzina
Journal:  JAMA Oncol       Date:  2016-12-01       Impact factor: 31.777

9.  Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated Cardiomyopathy.

Authors:  Bryon A Tompkins; Angela C Rieger; Victoria Florea; Monisha N Banerjee; Makoto Natsumeda; Evan D Nigh; Ana Marie Landin; Gianna M Rodriguez; Konstantinos E Hatzistergos; Ivonne Hernandez Schulman; Joshua M Hare
Journal:  J Am Heart Assoc       Date:  2018-07-12       Impact factor: 5.501

10.  Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]).

Authors:  Jorge Bartolucci; Fernando J Verdugo; Paz L González; Ricardo E Larrea; Ema Abarzua; Carlos Goset; Pamela Rojo; Ivan Palma; Ruben Lamich; Pablo A Pedreros; Gloria Valdivia; Valentina M Lopez; Carolina Nazzal; Francisca Alcayaga-Miranda; Jimena Cuenca; Matthew J Brobeck; Amit N Patel; Fernando E Figueroa; Maroun Khoury
Journal:  Circ Res       Date:  2017-09-26       Impact factor: 17.367

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.